248 related articles for article (PubMed ID: 16912174)
1. Coregulation of estrogen receptor by ERBB4/HER4 establishes a growth-promoting autocrine signal in breast tumor cells.
Zhu Y; Sullivan LL; Nair SS; Williams CC; Pandey AK; Marrero L; Vadlamudi RK; Jones FE
Cancer Res; 2006 Aug; 66(16):7991-8. PubMed ID: 16912174
[TBL] [Abstract][Full Text] [Related]
2. The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cells.
Naresh A; Long W; Vidal GA; Wimley WC; Marrero L; Sartor CI; Tovey S; Cooke TG; Bartlett JM; Jones FE
Cancer Res; 2006 Jun; 66(12):6412-20. PubMed ID: 16778220
[TBL] [Abstract][Full Text] [Related]
3. HER4 selectively coregulates estrogen stimulated genes associated with breast tumor cell proliferation.
Han W; Jones FE
Biochem Biophys Res Commun; 2014 Jan; 443(2):458-63. PubMed ID: 24333426
[TBL] [Abstract][Full Text] [Related]
4. Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells.
Junttila TT; Sundvall M; Lundin M; Lundin J; Tanner M; Härkönen P; Joensuu H; Isola J; Elenius K
Cancer Res; 2005 Feb; 65(4):1384-93. PubMed ID: 15735025
[TBL] [Abstract][Full Text] [Related]
5. The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone.
Williams CC; Allison JG; Vidal GA; Burow ME; Beckman BS; Marrero L; Jones FE
J Cell Biol; 2004 Nov; 167(3):469-78. PubMed ID: 15534001
[TBL] [Abstract][Full Text] [Related]
6. The ERalpha coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epithelium.
Rokicki J; Das PM; Giltnane JM; Wansbury O; Rimm DL; Howard BA; Jones FE
Mol Cancer; 2010 Jun; 9():150. PubMed ID: 20550710
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of the estrogen-inducible pS2 breast cancer marker gene by the ERR family of orphan nuclear receptors.
Lu D; Kiriyama Y; Lee KY; Giguère V
Cancer Res; 2001 Sep; 61(18):6755-61. PubMed ID: 11559547
[TBL] [Abstract][Full Text] [Related]
8. Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cells.
Hutcheson IR; Knowlden JM; Madden TA; Barrow D; Gee JM; Wakeling AE; Nicholson RI
Breast Cancer Res Treat; 2003 Sep; 81(1):81-93. PubMed ID: 14531500
[TBL] [Abstract][Full Text] [Related]
9. Nuclear ErbB4 signaling through H3K9me3 is antagonized by EGFR-activated c-Src.
Ishibashi K; Fukumoto Y; Hasegawa H; Abe K; Kubota S; Aoyama K; Kubota S; Nakayama Y; Yamaguchi N
J Cell Sci; 2013 Jan; 126(Pt 2):625-37. PubMed ID: 23230144
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of ERBB family mRNA expression in breast carcinomas.
Bièche I; Onody P; Tozlu S; Driouch K; Vidaud M; Lidereau R
Int J Cancer; 2003 Sep; 106(5):758-65. PubMed ID: 12866037
[TBL] [Abstract][Full Text] [Related]
11. Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer.
Ariazi EA; Clark GM; Mertz JE
Cancer Res; 2002 Nov; 62(22):6510-8. PubMed ID: 12438245
[TBL] [Abstract][Full Text] [Related]
12. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
[TBL] [Abstract][Full Text] [Related]
13. Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway.
Sauvé K; Lepage J; Sanchez M; Heveker N; Tremblay A
Cancer Res; 2009 Jul; 69(14):5793-800. PubMed ID: 19584281
[TBL] [Abstract][Full Text] [Related]
14. Direct coupling of the HER4 intracellular domain (4ICD) and STAT5A signaling is required to induce mammary epithelial cell differentiation.
Han W; Sfondouris ME; Jones FE
Biochem Biophys Rep; 2016 Sep; 7():323-327. PubMed ID: 28955922
[TBL] [Abstract][Full Text] [Related]
15. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
Kinoshita Y; Chen S
Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
[TBL] [Abstract][Full Text] [Related]
16. Human epidermal growth factor receptor 2 status modulates subcellular localization of and interaction with estrogen receptor alpha in breast cancer cells.
Yang Z; Barnes CJ; Kumar R
Clin Cancer Res; 2004 Jun; 10(11):3621-8. PubMed ID: 15173068
[TBL] [Abstract][Full Text] [Related]
17. HER4 tumor expression in breast cancer patients randomized to treatment with or without tamoxifen.
Göthlin Eremo A; Tina E; Wegman P; Stål O; Fransén K; Fornander T; Wingren S
Int J Oncol; 2015 Oct; 47(4):1311-20. PubMed ID: 26238412
[TBL] [Abstract][Full Text] [Related]
18. Ribozyme-mediated down-regulation of ErbB-4 in estrogen receptor-positive breast cancer cells inhibits proliferation both in vitro and in vivo.
Tang CK; Concepcion XZ; Milan M; Gong X; Montgomery E; Lippman ME
Cancer Res; 1999 Oct; 59(20):5315-22. PubMed ID: 10537315
[TBL] [Abstract][Full Text] [Related]
19. Estrogen stimulates transcription from the human prolactin distal promoter through AP1 and estrogen responsive elements in T47D human breast cancer cells.
Duan R; Ginsburg E; Vonderhaar BK
Mol Cell Endocrinol; 2008 Jan; 281(1-2):9-18. PubMed ID: 18022314
[TBL] [Abstract][Full Text] [Related]
20. WW domain containing E3 ubiquitin protein ligase 1 targets the full-length ErbB4 for ubiquitin-mediated degradation in breast cancer.
Li Y; Zhou Z; Alimandi M; Chen C
Oncogene; 2009 Aug; 28(33):2948-58. PubMed ID: 19561640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
